Phase 2 trials of the Covid-19 vaccine developed by Oxford University began on Tuesday at India's Bharati Vidyapeeth Medical College and Hospital in Pune. On Wednesday, 6 volunteers were administered a dose of the vaccine after their RT PCR and anti-body tests were cleared. The vaccine, named Covishield in India, is so far the most promising of the 150 vaccines being watched by the global community.
Be the first to comment